GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
4,234
Funds Holding Change
-26
Funds Holding Growth
-0.6%
Value
$845B
Holding in Top 10
675
Top 10 Change
-79
Top 10 Growth
-10%
Value Growth
-6%
New
169
Increased
1,854
Reduced
1,852
Closed
139
Capital Inflow
$25.7B
Capital Outflow
$24.6B
Net Capital Flow
+$1.07B
Capital Flow Change
-$11.1B
Calls
$10.6B
Puts
$10.3B
Net Calls
+$307M
Put/Call Ratio
0.97